Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in oral cavity cancers

Abstract

Background: Various studies have associated inflammation with carcinogenesis. But still, the role of inflammatory markers in oral cancer has not been evaluated extensively. Most of the existing studies have been done on patients of varied sites, and their sample size is also scarce. In this study, we have evaluated the impact of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on various clinicopathological factors and survival. Methodology: This was a retrospective analysis of prospectively collected data of 400 patients with oral squamous cell cancer. The pretreatment neutrophil and lymphocyte and platelet counts were recorded, and NLR and PLR were calculated for all patients. The NLR and PLR tertiles were correlated with the incidence of various clinicopathological factors and overall survival. Results: The median follow-up of the cohort was 36 months. The mean survival of the cohort was 41.7 months. PLR was associated with higher incidence of adverse clinicopathological factors. There was a trend of decreased overall survival with increasing NLR tertile. It was found to be significant only for the group which received adjuvant chemoradiotherapy (P 0.01). Patients with higher PLR values have been found to have a lower overall survival (P 0.006). Conclusion: NLR and PLR can be used to predict survival and outcomes in patients oral cavity cancer. PLR is a good predictor for adverse clinicopathological factors and survival. NLR can predict survival only in the subset of patients who have received chemotherapy.

Keywords

Chemotherapy - head-and-neck cancers - inflammatory markers - neutrophil-to-lymphocyte ratio - oral cancer - platelet-to-lymphocyte ratio - prognosis

Publikationsverlauf

Artikel online veröffentlicht:
08. Juni 2021

• References

• 1 Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99
• 2 Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-74
• 3 Ozturk K, Akyildiz NS, Uslu M, Gode S, Uluoz U. The effect of preoperative neutrophil, platelet and lymphocyte counts on local recurrence and survival in early-stage tongue cancer. Eur Arch Otorhinolaryngol 2016; 273: 4425-9
• 4 Nakashima H, Matsuoka Y, Yoshida R, Nagata M, Hirosue A, Kawahara K. et al. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study. BMC Cancer 2016; 16: 41
• 5 Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Semin Cancer Biol 2013; 23: 141-8
• 6 Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A. et al. Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 2011; 129: 2183-93
• 7 Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y. et al. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: Which is better as a prognostic factor in oral squamous cell carcinoma?. Ther Adv Med Oncol 2016; 8: 160-7
• 8 Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rödel F. et al. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer 2014; 110: 501-9
• 9 An X, Ding PR, Wang FH, Jiang WQ, Li YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2011; 32: 317-24
• 10 Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. et al. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck 2015; 37: 103-10
• 11 Perisanidis C, Kornek G, Pöschl PW, Holzinger D, Pirklbauer K, Schopper C. et al. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013; 30: 334
• 12 Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS. et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One 2013; 8: e83069
• 13 He JR, Shen GP, Ren ZF, Qin H, Cui C, Zhang Y. et al. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 2012; 34: 1769-76
• 14 Fang HY, Huang XY, Chien HT, Chang JT, Liao CT, Huang JJ. et al. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Laryngoscope 2013; 123: 2690-9
• 15 Tsai YD, Wang CP, Chen CY, Lin LW, Hwang TZ, Lu LF. et al. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 2014; 36: 947-53
• 16 Rachidi S, Wallace K, Wrangle JM, Day TA, Alberg AJ, Li Z. et al. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck 2016; 38: Suppl 1:E1068-74
• 17 Millrud CR, Månsson KvarnhammarA, Uddman R, Björnsson S, Riesbeck K, Cardell LO. et al. The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One 2012; 7: e51120
• 18 Grimm M, Rieth J, Hoefert S, Krimmel M, Rieth S, Teriete P. et al. Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma. Eur Arch Otorhinolaryngol 2016; 273: 3371-84